Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 30.3043.1840.9233.4137.60

What is the latest Core EBITDA Margin ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Margin ratio of DIVIS LABORATORIES is 30.30 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202330.30
Mar202243.18
Mar202140.92
Mar202033.41
Mar201937.60

How is Core EBITDA Margin of DIVIS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2023 30.3
-29.83
Mar2022 43.18
5.52
Mar2021 40.92
22.48
Mar2020 33.41
-11.14
Mar2019 37.6 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Margin ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹103,428.2 Cr -0.9% 4.2% 14.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹370,757.0 Cr 1.6% -3.7% 60% Stock Analytics
CIPLA ₹109,559.0 Cr -2% -4.6% 49.9% Stock Analytics
ZYDUS LIFESCIENCES ₹99,088.9 Cr -2.1% -0.9% 89.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,939.0 Cr -3.1% -4.7% 21.6% Stock Analytics
MANKIND PHARMA ₹90,040.7 Cr 3.1% -5.1% 57.7% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-0.9%

4.2%

14.3%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses